Adjust to target in type 2 diabetes - Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine

被引:120
作者
Bergenstal, Richard M. [1 ]
Johnson, Mary [1 ]
Powers, Margaret A. [1 ]
Wynne, Alan [2 ]
Vlajnic, Aleksandra [3 ]
Hollander, Priscilla [4 ]
Rendell, Marc [5 ]
机构
[1] Int Diabet Ctr Pk Nicollet, Minneapolis, MN 55416 USA
[2] Cotton ONeil Clin, Topeka, KS USA
[3] Sanofi Aventis US, Bridgewater, NJ USA
[4] Baylor Endocrine Ctr, Dallas, TX USA
[5] Creighton Diabet Ctr, Omaha, NE USA
关键词
D O I
10.2337/dc07-2137
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Carbohydrate counting is an effective approach to mealtime insulin adjustment in type I diabetes but has not been rigorously assessed in type 2 diabetes. We sought to compare an insulin-to-carbohydrate ratio with a simple algorithm for adjusting the dose of prandial insulin glusiline. RESEARCH AND DESIGN METHODS - This 24-week, multicenter, randomized, controlled study compared two algorithms for adjusting mealtime (glulisine) insulin along with a standard algorithm for adjusting background (glargine) insulin in 273 intent-to-treat patients with type 2 diabetes. Glulisine and glargine were adjusted weekly in both groups based on self-monitored blood glucose (SMBG) results from the previous week. The simple algorithm group was provided set doses of glulisine to take before each meal. The carbohydrate counting (carb count) group was provided an insulin-to-carbohydrate ratio to use for each meal and adjusted their glulisine dose based on the amount of carbohydrate consumed. RESULTS - A1C levels at week 24 were 6.70% (simple algorithm) and 6.54% (carb count). The respective mean A1C changes from baseline to 24 weeks were - 1.46 and - 1.59% (P = 0.24). A1C <7.0% was achieved by 73.2% (simple algorithm) and 69.2% (carb count) (P = 0.70) of subjects; respective values for A1C <6.5% were 44.3 and 49.5% (P = 0.28). The total daily dose of insulin was lower, and there was a trend toward less weight gain in carb count group patients. Severe hypoglycemia rates were low and equal in the two groups. CONCLUSIONS - Weekly basal-bolus insulin adjustments based on premeal and bedtime glucose patterns resulted in significant reductions in A1C. Having two effective approaches to delivering and adjusting rapid-acting mealtime insulin may increase physicians' and patients willingness to advance therapy to a basal-bolus insulin regimen.
引用
收藏
页码:1305 / 1310
页数:6
相关论文
共 25 条
  • [11] Gross Todd M, 2003, Diabetes Technol Ther, V5, P365, DOI 10.1089/152091503765691848
  • [12] What does postprandial hyperglycaemia mean?
    Heine, RJ
    Balkau, B
    Ceriello, A
    Del Prato, S
    Horton, ES
    Taskinen, MR
    [J]. DIABETIC MEDICINE, 2004, 21 (03) : 208 - 213
  • [13] Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes
    Holman, Rury R.
    Thorne, Kerensa I.
    Farmer, Andrew J.
    Davies, Melanie J.
    Keenan, Joanne F.
    Paul, Sanjoy
    Levy, Jonathan C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (17) : 1716 - 1730
  • [14] Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes
    Home, P
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (07) : 989 - 998
  • [15] Optimizing insulin delivery: assessment of three strategies in intensive diabetes management
    Kalergis, M
    Pacaud, D
    Strychar, I
    Meltzer, S
    Jones, PJH
    Yale, JF
    [J]. DIABETES OBESITY & METABOLISM, 2000, 2 (05) : 299 - 305
  • [16] Use of a plastic insulin dosage guide to correct blood glucose levels out of the target range and for carbohydrate counting in subjects with type 1 diabetes
    Kaufman, FR
    Halvorson, M
    Carpenter, S
    [J]. DIABETES CARE, 1999, 22 (08) : 1252 - 1257
  • [17] INTENSIVE INSULIN THERAPY PREVENTS THE PROGRESSION OF DIABETIC MICROVASCULAR COMPLICATIONS IN JAPANESE PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS - A RANDOMIZED PROSPECTIVE 6-YEAR STUDY
    OHKUBO, Y
    KISHIKAWA, H
    ARAKI, E
    MIYATA, T
    ISAMI, S
    MOTOYOSHI, S
    KOJIMA, Y
    FURUYOSHI, N
    SHICHIRI, M
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1995, 28 (02) : 103 - 117
  • [18] PERAGALLODITTKO V, 2001, CORE CURRICULUM DIAB
  • [19] A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes
    Raskin, P
    Klaff, L
    Bergenstal, R
    Hallé, JP
    Donley, D
    Mecca, T
    [J]. DIABETES CARE, 2000, 23 (11) : 1666 - 1671
  • [20] THE EFFECT OF LONG-TERM INTENSIFIED INSULIN-TREATMENT ON THE DEVELOPMENT OF MICROVASCULAR COMPLICATIONS OF DIABETES-MELLITUS
    REICHARD, P
    NILSSON, BY
    ROSENQVIST, U
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (05) : 304 - 309